Gene Therapy Update Highlights LDL Cholesterol Reduction

A gene therapy update reported significant reduction in harmful LDL cholesterol among patients.

A current affairs update highlighted an experimental gene therapy known as VERVE-102 for lowering LDL cholesterol. The therapy reportedly reduced harmful LDL cholesterol significantly in patients. Gene therapy is an important emerging area in biotechnology and precision medicine. The topic is useful for science and technology preparation, especially biotechnology and health innovation.